CTI Biopharma Crashing After FDA Puts Key Drug On Full Clinical Hold
February 10, 2016 at 13:01 PM EST
Shares of CTI BioPharma Corp (NASDAQ: CTIC), a bio-pharmaceutical company that focuses on treating blood-related cancers, plunged more ...
